n the future, human lifespan could be significantly extended due to advancements in gene editing, organ regeneration, and anti-aging drugs. Technologies like CRISPR may eliminate genetic diseases and slow down aging at a cellular level, while lab-grown organs and tissue engineering could replace failing body parts, reducing age-related health issues. Additionally, breakthroughs in anti-aging drugs, such as senolytics and telomerase activators, may rejuvenate cells and delay age-related decline. Combined, these innovations have the potential to not only extend lifespan but also enhance the quality of life in old age.
コメント